dbACP: A Comprehensive Database of Anti-Cancer Peptides

9 result(s) have been found!

Accession Name Sequence Source/Organism Mechanism Assay Type Cell Line Cancer Type Activity
dbacp05952 RGD-Las RGDLLRHVVKILSKYL Arg-Gly-Asp(RGD) tripeptide ana temporins Cell membrane disintegration MTT/MTS assay SW-1116 Colorectal cancer 81.465 Inhibition ratio at 50 µg/ml
dbacp05953 RGD-Las RGDLLRHVVKILSKYL Arg-Gly-Asp(RGD) tripeptide ana temporins Cell membrane disintegration MTT/MTS assay SMMC-7721 Liver cancer 86.175 Inhibition ratio at 50 µg/ml
dbacp05954 RGD-Las RGDLLRHVVKILSKYL Arg-Gly-Asp(RGD) tripeptide ana temporins Cell membrane disintegration MTT/MTS assay HeLa Cervical cancer 78.045 Inhibition ratio at 50 µg/ml
dbacp05955 RGD-Las RGDLLRHVVKILSKYL Arg-Gly-Asp(RGD) tripeptide ana temporins Cell membrane disintegration MTT/MTS assay HepG-2 Liver cancer 73.07 Inhibition ratio at 50 µg/ml
dbacp05956 RGD-Las RGDLLRHVVKILSKYL Arg-Gly-Asp(RGD) tripeptide ana temporins Cell membrane disintegration MTT/MTS assay BGC-823 Gastric cancer 73.705 Inhibition ratio at 50 µg/ml
dbacp05957 RGD-Las RGDLLRHVVKILSKYL Arg-Gly-Asp(RGD) tripeptide ana temporins Cell membrane disintegration MTT/MTS assay A-549 Lung cancer 52.50 Inhibition ratio at 50 µg/ml
dbacp05958 RGD-Las RGDLLRHVVKILSKYL Arg-Gly-Asp(RGD) tripeptide ana temporins Cell membrane disintegration MTT/MTS assay HL7702 Liver cancer 38.13 Inhibition ratio at 50 µg/ml
dbacp05959 RGD-Las RGDLLRHVVKILSKYL Arg-Gly-Asp(RGD) tripeptide ana temporins Cell membrane disintegration MTT/MTS assay HEK-293T Renal cancer 32.52 Inhibition ratio at 50 µg/ml
dbacp05960 RGD-Las RGDLLRHVVKILSKYL Arg-Gly-Asp(RGD) tripeptide ana temporins Cell membrane disintegration MTT/MTS assay MEC Breast cancer 29.33 Inhibition ratio at 50 µg/ml